Avi Kapoor Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom Broadcom expanded its multi-year partnership with Telia Company to advance telecom and cloud infrastructure using VMware's ...

Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

Section 232 investigations target pharmaceutical ingredients and chips, with public comment open for 21 days starting ...

Shares in private equity giant KKR (KKR) were higher today after it made a $1.2 billion takeover offer for Swedish biotechnology company ...

A Dallas-based company says that it has resurrected the ... and a wonderful example of the power of biotechnology to protect species, both extant and extinct.” Drew Weisholtz is a reporter ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president ...

Analysts exoect revenue to rise by more than 180%, to $762 million, this year, and then grow another 45%, to $1.1 billion, next year, pushing the biotech company out of the red and into the black ...

NEW YORK, March 26 (Reuters) - Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...